Ruth Wright

Biotech vs Medtech: Differences in Mapping an IP Portfolio

This article was originally published on Biotech and Money as a two-part series. Read part one here. IP portfolio management is often overlooked, but is extremely important if the goal is to protect products or services in the most cost-efficient way possible. However, the process of mapping an IP portfolio to...

Read more

Biotech vs Medtech: Divergence in Intellectual Property Strategy

The landscape of innovation and investment in the healthcare sector has changed dramatically with the digital revolution and the rise of medtech – the physical devices used in healthcare – ranging from drug delivery devices to diagnostic kits and software for the interpretation of health and wellbeing data. Investors in...

Read more

What makes a digital health business a medtech business?

These days, with digital transformation and disruption on everyone’s lips, there is no shortage of companies across a wide range of sectors trying to claim to be a technology business as a badge of honour. It has never been more challenging to determine whether a company is genuinely a technology...

Read more

To patent or not to patent?

As Fiona Stevens and I explained in our recent presentation at the Angels in MedCity Investor Workshop, IP due diligence should never be a tick-box exercise. A company’s decision as to whether (or not) to file a patent application should be carefully reasoned in view of their business plan and...

Read more

Stop seeing double: how the alcohol industry is using IP to beat the counterfeiters

According to The Food Crime Annual Strategic Assessment[1], published recently by the Food Standard Agency’s National Food Crime Unit, piracy could account for more than one billion pounds of annual UK food and drink trade. Different businesses benefit from usage of different anti-counterfeiting measures. These can present opportunities in terms...

Read more